175 related articles for article (PubMed ID: 17052808)
1. Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition.
Guri AJ; Hontecillas R; Bassaganya-Riera J
Clin Nutr; 2006 Dec; 25(6):871-85. PubMed ID: 17052808
[TBL] [Abstract][Full Text] [Related]
2. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
Guri AJ; Hontecillas R; Bassaganya-Riera J
J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors and the metabolic syndrome.
Bragt MC; Popeijus HE
Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
[TBL] [Abstract][Full Text] [Related]
4. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
Feige JN; Gelman L; Michalik L; Desvergne B; Wahli W
Prog Lipid Res; 2006 Mar; 45(2):120-59. PubMed ID: 16476485
[TBL] [Abstract][Full Text] [Related]
5. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
Yahia RB; Lichnovská R; Brychta T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
[TBL] [Abstract][Full Text] [Related]
7. PPARs: molecular targets in the pharmacogenomics era.
Seda O; Sedová L
Prague Med Rep; 2004; 105(3):223-36. PubMed ID: 15782550
[TBL] [Abstract][Full Text] [Related]
8. PPARs and the complex journey to obesity.
Evans RM; Barish GD; Wang YX
Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233
[TBL] [Abstract][Full Text] [Related]
9. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism.
Flachs P; Rossmeisl M; Bryhn M; Kopecky J
Clin Sci (Lond); 2009 Jan; 116(1):1-16. PubMed ID: 19037880
[TBL] [Abstract][Full Text] [Related]
11. [The roles of PPAR, C/EBP and FoxO families in adipocyte differentiation and proliferation].
Kitamura T; Kitamura Y
Nihon Rinsho; 2011 Jan; 69 Suppl 1():259-63. PubMed ID: 21766606
[No Abstract] [Full Text] [Related]
12. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
[TBL] [Abstract][Full Text] [Related]
13. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
Yumuk VD
Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus.
Viana Abranches M; Esteves de Oliveira FC; Bressan J
Nutr Hosp; 2011; 26(2):271-9. PubMed ID: 21666962
[TBL] [Abstract][Full Text] [Related]
16. PPARs and their effects on the cardiovascular system.
Oyekan A
Clin Exp Hypertens; 2011; 33(5):287-93. PubMed ID: 21721973
[TBL] [Abstract][Full Text] [Related]
17. [Role of the fatty acids in ovarian functions: involvement of peroxisome proliferator-activated receptors (PPAR) and adipokines].
Dupont J; Froment P; Ramé C; Pierre P; Coyral-Castel S; Chabrolle C
Gynecol Obstet Fertil; 2008 Dec; 36(12):1230-8. PubMed ID: 19013096
[TBL] [Abstract][Full Text] [Related]
18. Quantitative image analysis in adipose tissue using an automated image analysis system: differential effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice.
Okamoto Y; Higashiyama H; Inoue H; Kanematsu M; Kinoshita M; Asano S
Pathol Int; 2007 Jun; 57(6):369-77. PubMed ID: 17539968
[TBL] [Abstract][Full Text] [Related]
19. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
20. Nitro-fatty acids as novel electrophilic ligands for peroxisome proliferator-activated receptors.
Ferreira AM; Minarrieta L; Lamas Bervejillo M; Rubbo H
Free Radic Biol Med; 2012 Nov; 53(9):1654-63. PubMed ID: 22982052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]